Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
16 Syndrome in a Patient With Multiple Sclerosis.
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Perception of muscular effort in multiple sclerosis.
Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
Role of the nucleolus in neurodegenerative disease with particular reference to the retina: a review.
BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in Multiple Sclerosis patients.
Validity of Oxygen Uptake Efficiency Slope in patients with multiple sclerosis.
The fibrotic scar in neurological disorders.
Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels.
Internal jugular and vertebral vein volume flow in patients with clinically isolated syndrome or mild multiple sclerosis and healthy controls: results from a prospective sonographer-blinded study.
Neutrophils Amplify Autoimmune Central Nervous System Infiltrates by Maturing Local APCs.
USPIO-Enhanced MRI Neuroimaging: A Review.
Parkinsonism associated with multiple sclerosis: A report of eight new cases and a review on the literature.
Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
KCHO-1, a Novel Antineuroinflammatory Agent, Inhibits Lipopolysaccharide-Induced Neuroinflammatory Responses through Nrf2-Mediated Heme Oxygenase-1 Expression in Mouse BV2 Microglia Cells.
Multiple sclerosis: Cannabis use is associated with deleterious brain changes in patients with multiple sclerosis.
Interleukin-17 in human inflammatory diseases.
Multiple sclerosis guideline production takes off.
Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration.
The Blood-Brain Barrier in Multiple Sclerosis: MicroRNAs as Key Regulators.
Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis.
Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
New markers of early cardiovascular risk in multiple sclerosis patients: Oxidized-LDL correlates with clinical staging.
Signaling mechanisms regulating myelination in the central nervous system.
Pages
« first
‹ previous
…
457
458
459
460
461
462
463
464
465
…
next ›
last »